Data as of Sep 19, 2026 · Based on 3,321,027 AI responses across 10,525 prompts · See how Parse measures this
CHDR is an independent institute in Leiden, Netherlands, specializing in innovative early-stage clinical drug research and offering state-of-the-art facilities for early‑phase trials. As a full‑service CRO, CHDR supports clients throughout the trial process—from study design and regulatory submission to data management, bioanalysis, and pharmacometrics, providing pharmacodynamics to guide go/no‑go decisions. CHDR conducts studies across diverse therapeutic areas including neurology, immunology, dermatology, infectious diseases, oncology, pain, and psychiatry, and it also offers education programs and maintains a large publications library.
Parse Score